文献速递关节外科

肺动脉高压患者初次与翻修全髋关节置换术的围手术期死亡率和内科并发症高

Primary and Revision Total Hip Arthroplasty in Patients With Pulmonary Hypertension: High Perioperative Mortality and Medical Complications.
PubMed 文献 · J Arthroplasty · 2022-12-17

本研究回顾性分析2000至2016年一家三级医疗中心638例肺动脉高压患者的508例初次和191例翻修全髋关节置换术,发现初次和翻修术后90天死亡率分别为1.8%和3.1%,内科并发症发生率分别为6.2%和13.1%,死亡风险分别约为无肺动脉高压患者的2.69倍和2.04倍。

要点

  • 肺动脉高压患者初次全髋置换90天死亡率为1.8%,翻修为3.1%。
  • 90天内内科并发症发生率初次为6.2%,翻修为13.1%。
  • 死亡风险较无肺动脉高压患者升高,初次HR 2.69,翻修HR 2.04。

核心结论

  • 肺动脉高压患者行初次和翻修全髋关节置换术的死亡风险增加,且术后90天内内科并发症发生率高。
  • 作者认为应考虑进行风险告知、内科优化并转诊至擅长处理复杂内科问题的医疗中心。

研究设计与样本

  • 回顾性研究,纳入2000至2016年一家三级医疗中心的638例肺动脉高压患者,共行508例初次全髋关节置换术和191例翻修全髋关节置换术。
  • 患者定期随访至死亡、翻修手术或末次临床随访,围手术期内科并发症逐一回顾,采用标准化死亡比和Cox比例风险回归模型分析死亡风险,并以死亡为竞争风险计算累积发生率。
  • 证据等级为Level IV。

主要发现

  • 初次全髋关节置换术90天死亡率为1.8%,翻修全髋关节置换术为3.1%。
  • 与无肺动脉高压的初次全髋关节置换术患者相比,肺动脉高压患者死亡风险比约为2.69;与无肺动脉高压的翻修全髋关节置换术患者相比,风险比约为2.04。
  • 术后90天内内科并发症发生率在初次全髋关节置换术为6.2%,在翻修全髋关节置换术为13.1%。
  • 初次和翻修全髋关节置换术后10年任何翻修的累积发生率分别为9%和14%。

临床怎么用

  • 作者认为,对于肺动脉高压患者行初次和翻修全髋关节置换术,应考虑进行风险告知、内科优化并转诊至擅长处理复杂内科问题的医疗中心。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Perioperative medical management during total hip arthroplasty (THA) is continuously improving, allowing an increasing number of medically complex patients to undergo total joint arthroplasty. This study examined mortalities, medical complications, implant survivorships, and clinical outcomes of THA in patients who have pulmonary hypertension (HTN). METHODS: We identified 638 patients who had pulmonary HTN and underwent 508 primary THAs and 191 revision THAs from 2000 to 2016 at a tertiary care center. Patients were followed up at regular intervals until death, revision surgery, or last clinical follow-up. Perioperative medical complications were individually reviewed. The risk of death was examined by calculating standardized mortality ratios and Cox proportional hazards regression models. Cumulative incidence analyses were used for reporting mortality, reoperation, and revision with death as a competing risk. RESULTS: The 90-day mortality was 1.8% and 3.1% for primary and revision THAs, respectively. The risk of death was approximately two-fold higher compared to primary (hazard ratio 2.69) and revision (hazard ratio 2.04) THA patients who did not have pulmonary HTN. Rate of medical complications within 90 days from surgery were 6.2% and 13.1% in primary and revision THAs, respectively. The 10-year cumulative incidence of any revision was 9% and 14% following primaries and revisions, respectively. CONCLUSION: Patients who had pulmonary HTN undergoing primary and revision THAs had an increased risk of death and experienced a high rate of medical complications within 90 days of surgery. Counseling of risks, medical optimization, and referral to medical centers expert at managing complex medical problems should be considered. LEVEL OF EVIDENCE: Level IV.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Baker CE, Chalmers BP, Taunton MJ, et al. Primary and Revision Total Hip Arthroplasty in Patients With Pulmonary Hypertension: High Perioperative Mortality and Medical Complications. J Arthroplasty. 2022. PMID: 36535439. doi:10.1016/j.arth.2022.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。